Paricalcitol is a synthetic vitamin D analogue classified as a selective vitamin D receptor agonist, primarily utilized to manage secondary hyperparathyroidism in patients with chronic kidney disease.… Read more
![Chemical structure of (1R,3aR,7aR)-Octahydro-1-[(1R,2Z,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1186587-53-0-1R3aR7aR-Octahydro-1-1R2Z4S-5-hydroxy-145-trimethyl-2-hexen-1-yl-7a-methyl-4H-inden-4-one.png&w=3840&q=75)







































Paricalcitol is a synthetic vitamin D analogue classified as a selective vitamin D receptor agonist, primarily utilized to manage secondary hyperparathyroidism in patients with chronic kidney disease. To ensure rigorous quality control and regulatory compliance during the manufacture of the active pharmaceutical ingredient, laboratories require high-quality analytical materials. This category provides a comprehensive selection of reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for accurate impurity profiling, supporting method development, and facilitating precise quantification in complex biological matrices. Whether used for identifying unknown degradation products or validating analytical assays, these compounds enable consistent, reliable drug analysis throughout the pharmaceutical lifecycle.